SCHEMBL29640533

SCHEMBL29640533

NC(=O)C(CCC(F)(F)F)C(CC(F)(F)F)C(N)=O

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NOTCH1 P46531 6/20 0.34
NOTCH3 Q9UM47 5/20 0.34
RBPJ Q06330 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22660114 0.91 NOTCH1 (0.34) NOTCH1NOTCH3RBPJ
SCHEMBL29640534 0.84 NOTCH1 (0.33) NOTCH1NOTCH3RBPJ
SCHEMBL12868885 0.76 SLC1A3 (0.34)
SCHEMBL12868892 0.76 SLC1A3 (0.34)
SCHEMBL12868893 0.76 SLC1A3 (0.34)
SCHEMBL4057289 0.72 NOS2 (0.32)
SCHEMBL24108958 0.70 NOS2 (0.42)
SCHEMBL1642298 0.70 NOS2 (0.42)
SCHEMBL1876375 0.70 NOS2 (0.42)
SCHEMBL3990465 0.69 CA1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3969001-A1 BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS FOR TREATING NOTCH-ACTIVATED BREAST CANCER Ayala Pharmaceuticals Inc. (US) 2022-03-23 EP claimed